Press "Enter" to skip to content

A Ray Of Hope For Peanut Allergics―Report Suggests

There are a number of children in the world, like Emily Clover, who have an allergy to a particular food substance, peanut, and have to miss out on quite many things because of this pathology. However, a recent study conducted has successfully tested a biological product that could combat the harmful effects of peanut and make life a little bit easier for the less fortunate, in this aspect.

People with peanut allergy may have life-threatening anaphylactic reactions on consuming peanuts, which can constrict the airway or cause erythematous rashes all over the body. Though these people will consciously stay away from peanuts, sometimes, accidental consumption might happen which might prove to be fatal as well. Therefore, the development of an experimental drug was received well by a lot of people suffering from this anomaly, as being rid of it was the main motivation. The therapeutic product has been manufactured by Aimmune Therapeutics Limited and has already submitted its reports for approval for marketing and selling it.

The purpose of making the product was not to cure people of the allergy but to increase the threshold level of tolerance of peanut so that accidental consumption of small amounts didn’t escalate to something dangerous. A number of test subjects were gathered from a variety of age group and 2/3rd of them were given the dose. Surprisingly, the product was nothing but minute quantities of peanut powder itself. The idea was to acclimatize the body to a certain quantity of peanuts and then gradually increasing it. About 1/3rd of them were given placebos.

At the end, there was a final test, where the participants had to consume one whole peanut and then two, in the presence of skilled doctors. Most of them didn’t show any adverse allergic reaction to peanut, while some had a minor stomach ache with passing cramps. Very few had to be administered emergency epinephrine. The numbers were higher in the control group. Thus, it was proved that a resistance had been developed against the allergy and once it became available as a medicinal drug, it would benefit many.

There are certain aspects of the medicine that need to be kept in mind though. It has to be taken regularly, after dinner, making it a ritualistic dose-specific cumbersome task. Leaving the dose and continuing later can cause more problems. It doesn’t even taste good, said Emily Clover, who was one of the test subjects. However, the results have opened the doors for a lot more research and will be instrumental in stopping any mishap from happening from a peanut allergy.

 

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *